Targeting RNA Structure to Inhibit Editing in Trypanosomes.

Area of Science:

• Biochemistry
• Molecular Biology
• Drug Discovery

Background:

• Mitochondrial RNA editing in trypanosomes is a unique pathway absent in humans, making it a promising drug target.
• Previous drug development efforts focused on enzymes, not the RNA editing substrate itself.

Purpose of the Study:

• To identify novel compounds that inhibit trypanosome RNA editing by targeting the U-helix structure.
• To develop new therapeutic strategies against trypanosome infections.

Main Methods:

• Virtual screening of 262,000 compounds against the U-helix RNA structure.
• Chemoinformatic filtering and molecular dynamics simulations.
• Microscale thermophoresis and UV melting assays to validate compound binding and effect.

Main Results:

• Identified 15 compounds with stable interactions in the U-helix deep groove.
• Five compounds demonstrated low-micromolar to nanomolar binding affinities.
• Compounds successfully increased the melting temperature of the U-helix, indicating binding and structural stabilization.

Conclusions:

• The identified compounds are potential leads for developing novel anti-trypanosome drugs.
• These compounds can serve as valuable research tools to investigate the role of RNA structure in trypanosomal RNA editing.